Emergent Health Corp
EMGE · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | -$461 | $461 | $334 |
| % Growth | 100% | -200% | 37.8% | – |
| Cost of Goods Sold | $0 | -$171 | $171 | $163 |
| Gross Profit | $0 | -$290 | $290 | $172 |
| % Margin | – | 62.9% | 62.9% | 51.4% |
| R&D Expenses | $0 | $3 | $4 | $11 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | -$443 | $637 | $343 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | -$440 | $641 | $353 |
| Operating Income | -$3 | $150 | -$351 | -$182 |
| % Margin | – | -32.6% | -76.3% | -54.3% |
| Other Income/Exp. Net | -$62 | -$60 | -$62 | -$75 |
| Pre-Tax Income | -$65 | $91 | -$414 | -$257 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65 | $91 | -$414 | -$257 |
| % Margin | – | -19.7% | -89.8% | -76.8% |
| EPS | -0 | 0 | -0.001 | -0.001 |
| % Growth | -200% | 120% | -66.7% | – |
| EPS Diluted | -0 | 0 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 426,951 | 426,951 | 426,951 | 426,951 |
| Weighted Avg Shares Out Dil | 426,951 | 499,551 | 426,951 | 426,951 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$1 |
| Interest Expense | $62 | $60 | $62 | $74 |
| Depreciation & Amortization | $0 | $5 | $5 | $5 |
| EBITDA | -$3 | $155 | -$346 | -$178 |
| % Margin | – | -33.7% | -75.2% | -53.2% |